Amphotericin B Liposomal Injection
Generic name: Pronounced as (am foe ter' I sin)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 05/15/2016
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What side effects can this medication cause?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
Why is this medication prescribed?
Amphotericin B liposomal injection is used to treat fungal infections such as cryptococcal meningitis (a fungal infection of the lining of the spinal cord and brain) and visceral leishmaniasis (a parasitic disease that usually affects spleen, liver, and bone marrow) in certain people. It is also used to treat certain fungal infections in people who cannot receive conventional amphotericin B therapy. Amphotericin B liposomal injection is in a class of medications called antifungals. It works by slowing the growth of fungi that cause infection.
How should this medicine be used?
Amphotericin B liposomal injection comes as a suspension (liquid) to be injected intravenously (into a vein). It is usually infused intravenously once daily, or for the treatment of leishmaniasis on specific days, over a period of 2 hours. If previous doses are tolerated, this medication may be given over a period of 1 hour. The length of your treatment depends on your general health, how you tolerate the medication, and the type of infection you have.
You may experience a reaction while you receive a dose of amphotericin B liposomal complex injection. These reactions usually happen 1 to 3 hours after starting your infusion and are more severe with the first few doses. Your health care provider may prescribe other medications to decrease these side effects. Tell your doctor immediately if you experience any of these symptoms while you receive amphotericin B liposomal complex injection: fever, chills, nausea, vomiting, flushing, back pain with or without chest tightness, chest pain, shortness of breath, breathing problems, or a fast, irregular, or pounding heartbeat.
You may receive amphotericin B liposomal injection in a hospital or you may use the medication at home. If you will be using amphotericin B liposomal injection at home, your healthcare provider will show you how to infuse the medication. Be sure that you understand these directions, and ask your healthcare provider if you have any questions. Ask your healthcare provider what to do if you have any problems infusing amphotericin B liposomal injection.
If your symptoms do not improve or get worse while receiving amphotericin B liposomal injection, tell your doctor. If you still have symptoms of infection after you finish amphotericin B liposomal injection, tell your doctor.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before receiving amphotericin B liposomal injection,
-
tell your doctor and pharmacist if you are allergic to amphotericin B, any other medications, or any of the ingredients in amphotericin B liposomal injection. Ask your pharmacist for a list of the ingredients.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: aminoglycoside antibiotics such as amikacin, gentamicin, or tobramycin (Bethkis, Kitabis Pak, Tobi); antifungals such as clotrimazole, fluconazole (Diflucan), itraconazole (Onmel, Sporanox), ketoconazole (Extina, Nizoral, Xolegel), and miconazole (Oravig, Monistat); medications for the treatment of cancer; corticotropin (H.P. Acthar Gel); cyclosporine (Gengraf, Neoral, Sandimmune); digoxin (Lanoxin); flucytosine (Ancobon); and steroids taken orally such as dexamethasone, methylprednisolone (Medrol), and prednisone (Rayos). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
-
tell your doctor if you are receiving leukocyte (white blood cell) transfusions.
-
tell your doctor if you have or have ever had kidney disease.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while receiving amphotericin B liposomal injection, call your doctor. Do not breast-feed while receiving amphotericin B liposomal injection.
-
if you are having surgery, including dental surgery, tell the doctor or dentist that you are receiving amphotericin B liposomal injection.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What side effects can this medication cause?
-
Amphotericin B liposomal injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
stomach pain
-
heartburn
-
diarrhea
-
constipation
-
loss of appetite
-
redness or swelling at the injection site
-
pale skin
-
shortness of breath
-
dizziness
-
headache
-
coldness in the hands and feet
-
-
Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:
-
rash
-
hives
-
difficulty breathing
-
itching
-
swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs
-
chest pain or tightness
-
black and tarry stools
-
decreased urination
-
blood in the urine
-
-
Amphotericin B liposomal injection may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests during your treatment to check your body's response to amphotericin B liposomal injection.
Before having any laboratory test, tell your doctor and the laboratory personnel that you are receiving amphotericin B liposomal injection.
Do not let anyone else use your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Montelukast | Montelukast The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Amphotericin B. |
Leflunomide | Leflunomide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Leflunomide. |
Atorvastatin | Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Amphotericin B. |
Alendronate | Alendronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Alendronic acid. |
Aminophylline | Aminophylline The metabolism of Aminophylline can be decreased when combined with Amphotericin B. |
Candesartan | Candesartan Amphotericin B may increase the hypotensive activities of Candesartan. |
Cilostazol | Cilostazol The metabolism of Cilostazol can be decreased when combined with Amphotericin B. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Amphotericin B may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level. |
Fenofibrate | Fenofibrate Amphotericin B may decrease the excretion rate of Fenofibrate which could result in a higher serum level. |
Guanfacine | Guanfacine Amphotericin B may decrease the excretion rate of Guanfacine which could result in a higher serum level. |
Magnesium Hydroxide | Magnesium Hydroxide Amphotericin B may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level. |
Mycophenolate | Mycophenolate Amphotericin B may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level. |
Nafarelin | Nafarelin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Amphotericin B. |
Olsalazine | Olsalazine The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Olsalazine. |
Paregoric | Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Amphotericin B. |
Penbutolol | Penbutolol The risk or severity of adverse effects can be increased when Amphotericin B is combined with Acebutolol. |
Potassium | Potassium Amphotericin B may decrease the excretion rate of Potassium cation which could result in a higher serum level. |
Prednisone | Prednisone The risk or severity of hypokalemia can be increased when Prednisone is combined with Amphotericin B. |
Ranitidine | Ranitidine Amphotericin B may decrease the excretion rate of Ranitidine which could result in a higher serum level. |
Reserpine | Reserpine Amphotericin B may decrease the excretion rate of Reserpine which could result in a higher serum level. |
Rizatriptan | Rizatriptan Amphotericin B may decrease the excretion rate of Rizatriptan which could result in a higher serum level. |
Sumatriptan | Sumatriptan Amphotericin B may decrease the excretion rate of Sumatriptan which could result in a higher serum level. |
Tacrolimus | Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Amphotericin B. |
Tiludronate | Tiludronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Etidronic acid. |
Tizanidine | Tizanidine The therapeutic efficacy of Tizanidine can be decreased when used in combination with Amphotericin B. |
Triamcinolone | Triamcinolone The risk or severity of hypokalemia can be increased when Triamcinolone is combined with Amphotericin B. |
Ampicillin Injection | Ampicillin Injection Amphotericin B may decrease the excretion rate of Ampicillin which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection Amphotericin B may decrease the excretion rate of Doxycycline which could result in a higher serum level. |
Fluconazole Injection | Fluconazole Injection The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Fluconazole. |
Foscarnet Injection | Foscarnet Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Foscarnet. |
Hydromorphone Injection | Hydromorphone Injection Amphotericin B may decrease the excretion rate of Hydromorphone which could result in a higher serum level. |
Levofloxacin Injection | Levofloxacin Injection Amphotericin B may decrease the excretion rate of Levofloxacin which could result in a higher serum level. |
Meperidine Injection | Meperidine Injection Amphotericin B may decrease the excretion rate of Meperidine which could result in a higher serum level. |
Methylprednisolone Injection | Methylprednisolone Injection The risk or severity of hypokalemia can be increased when Methylprednisolone is combined with Amphotericin B. |
Metoclopramide Injection | Metoclopramide Injection Amphotericin B may decrease the excretion rate of Metoclopramide which could result in a higher serum level. |
Morphine Injection | Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Amphotericin B. |
Pamidronate Injection | Pamidronate Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Pamidronic acid. |
Vancomycin Injection | Vancomycin Injection Amphotericin B may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Zidovudine Injection | Zidovudine Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Amphotericin B. |
Altretamine | Altretamine Amphotericin B may decrease the excretion rate of Amphetamine which could result in a higher serum level. |
Cefuroxime | Cefuroxime The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefuroxime. |
Cyclosporine | Cyclosporine Amphotericin B may increase the nephrotoxic activities of Cyclosporine. |
Torsemide | Torsemide The risk or severity of adverse effects can be increased when Amphotericin B is combined with Torasemide. |
Olanzapine | Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Amphotericin B. |
Dofetilide | Dofetilide The metabolism of Dofetilide can be decreased when combined with Amphotericin B. |
Eprosartan | Eprosartan The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Eprosartan. |
Meloxicam | Meloxicam The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Meloxicam. |
Oxcarbazepine | Oxcarbazepine The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Amphotericin B. |
Pantoprazole | Pantoprazole Amphotericin B may decrease the excretion rate of Pantoprazole which could result in a higher serum level. |
Risedronate | Risedronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Risedronic acid. |
Telmisartan | Telmisartan The risk or severity of adverse effects can be increased when Amphotericin B is combined with Telmisartan. |
Temozolomide | Temozolomide Amphotericin B may decrease the excretion rate of Temozolomide which could result in a higher serum level. |
Zaleplon | Zaleplon Amphotericin B may decrease the excretion rate of Zaleplon which could result in a higher serum level. |
Linezolid | Linezolid Linezolid may increase the orthostatic hypotensive activities of Amphotericin B. |
Perindopril | Perindopril Amphotericin B may decrease the excretion rate of Perindopril which could result in a higher serum level. |
Tenofovir | Tenofovir Amphotericin B may increase the nephrotoxic activities of Tenofovir. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Choline magnesium trisalicylate. |
Sirolimus | Sirolimus The metabolism of Sirolimus can be decreased when combined with Amphotericin B. |
Eplerenone | Eplerenone The risk or severity of adverse effects can be increased when Amphotericin B is combined with Eplerenone. |
Olmesartan | Olmesartan The risk or severity of adverse effects can be increased when Amphotericin B is combined with Olmesartan. |
Zonisamide | Zonisamide Zonisamide may decrease the nephrotoxic activities of Amphotericin B. |
Aripiprazole | Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Amphotericin B. |
Atomoxetine | Atomoxetine Amphotericin B may decrease the excretion rate of Atomoxetine which could result in a higher serum level. |
Atazanavir | Atazanavir The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Atazanavir. |
Almotriptan | Almotriptan Amphotericin B may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Mefloquine | Mefloquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Amphotericin B. |
Rosuvastatin | Rosuvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Rosuvastatin. |
Vardenafil | Vardenafil The metabolism of Vardenafil can be decreased when combined with Amphotericin B. |
Alfuzosin | Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Amphotericin B. |
Emtricitabine | Emtricitabine Amphotericin B may decrease the excretion rate of Emtricitabine which could result in a higher serum level. |
Memantine | Memantine Amphotericin B may decrease the excretion rate of Memantine which could result in a higher serum level. |
Tadalafil | Tadalafil Amphotericin B may decrease the excretion rate of Tadalafil which could result in a higher serum level. |
Apomorphine Injection | Apomorphine Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Apomorphine. |
Infliximab Injection | Infliximab Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Amphotericin B. |
Duloxetine | Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Amphotericin B is combined with Duloxetine. |
Norethindrone | Norethindrone The metabolism of Norethisterone can be decreased when combined with Amphotericin B. |
Tinidazole | Tinidazole Amphotericin B may decrease the excretion rate of Tinidazole which could result in a higher serum level. |
Bosentan | Bosentan Amphotericin B may increase the hypotensive activities of Bosentan. |
Cefditoren | Cefditoren Amphotericin B may decrease the excretion rate of Cefdinir which could result in a higher serum level. |
Cyanocobalamin Injection | Cyanocobalamin Injection Amphotericin B may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level. |
Erlotinib | Erlotinib The metabolism of Erlotinib can be decreased when combined with Amphotericin B. |
Eszopiclone | Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Amphotericin B. |
Ganciclovir | Ganciclovir Amphotericin B may decrease the excretion rate of Ganciclovir which could result in a higher serum level. |
Ribavirin | Ribavirin Amphotericin B may decrease the excretion rate of Ribavirin which could result in a higher serum level. |
Valganciclovir | Valganciclovir Amphotericin B may decrease the excretion rate of Valganciclovir which could result in a higher serum level. |
Voriconazole | Voriconazole The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Voriconazole. |
Zoledronic Acid Injection | Zoledronic Acid Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Zoledronic acid. |
Adefovir | Adefovir The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Adefovir. |
Dextroamphetamine | Dextroamphetamine Amphotericin B may decrease the excretion rate of Amphetamine which could result in a higher serum level. |
Ibandronate | Ibandronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Ibandronate. |
Isocarboxazid | Isocarboxazid Isocarboxazid may increase the orthostatic hypotensive activities of Amphotericin B. |
Ramelteon | Ramelteon Amphotericin B may decrease the excretion rate of Ramelteon which could result in a higher serum level. |
Fentanyl | Fentanyl The metabolism of Fentanyl can be decreased when combined with Amphotericin B. |
Pregabalin | Pregabalin The therapeutic efficacy of Pregabalin can be decreased when used in combination with Amphotericin B. |
Felbamate | Felbamate The therapeutic efficacy of Felbamate can be decreased when used in combination with Amphotericin B. |
Ranolazine | Ranolazine Amphotericin B may decrease the excretion rate of Ranolazine which could result in a higher serum level. |
Rasagiline | Rasagiline Rasagiline may increase the orthostatic hypotensive activities of Amphotericin B. |
Sitagliptin | Sitagliptin Amphotericin B may decrease the excretion rate of Sitagliptin which could result in a higher serum level. |
Varenicline | Varenicline Amphotericin B may decrease the excretion rate of Varenicline which could result in a higher serum level. |
Albuterol | Albuterol Amphotericin B may decrease the excretion rate of Salbutamol which could result in a higher serum level. |
Paliperidone | Paliperidone Amphotericin B may decrease the excretion rate of Paliperidone which could result in a higher serum level. |
Bortezomib | Bortezomib The metabolism of Amphotericin B can be decreased when combined with Bortezomib. |
Clofarabine Injection | Clofarabine Injection Amphotericin B may decrease the excretion rate of Clofarabine which could result in a higher serum level. |
Lubiprostone | Lubiprostone Amphotericin B may decrease the excretion rate of Lubiprostone which could result in a higher serum level. |
Posaconazole | Posaconazole The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Posaconazole. |
Aliskiren | Aliskiren The risk or severity of adverse effects can be increased when Amphotericin B is combined with Aliskiren. |
Pemetrexed Injection | Pemetrexed Injection Amphotericin B may decrease the excretion rate of Pemetrexed which could result in a higher serum level. |
Nabilone | Nabilone The risk or severity of adverse effects can be increased when Nabilone is combined with Amphotericin B. |
Retapamulin | Retapamulin The metabolism of Retapamulin can be decreased when combined with Amphotericin B. |
Sorafenib | Sorafenib The metabolism of Sorafenib can be decreased when combined with Amphotericin B. |
Sunitinib | Sunitinib The metabolism of Sunitinib can be decreased when combined with Amphotericin B. |
Levocetirizine | Levocetirizine Amphotericin B may decrease the excretion rate of Levocetirizine which could result in a higher serum level. |
Pegaptanib Injection | Pegaptanib Injection Amphotericin B may decrease the excretion rate of Pegaptanib which could result in a higher serum level. |
Dasatinib | Dasatinib The metabolism of Dasatinib can be decreased when combined with Amphotericin B. |
Azacitidine Injection | Azacitidine Injection Amphotericin B may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Ivermectin | Ivermectin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Amphotericin B. |
Temsirolimus | Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Amphotericin B. |
Lenalidomide | Lenalidomide Amphotericin B may decrease the excretion rate of Lenalidomide which could result in a higher serum level. |
Nilotinib | Nilotinib The metabolism of Nilotinib can be decreased when combined with Amphotericin B. |
Raltegravir | Raltegravir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Raltegravir. |
Budesonide | Budesonide The risk or severity of hypokalemia can be increased when Budesonide is combined with Amphotericin B. |
Desmopressin | Desmopressin Amphotericin B may decrease the excretion rate of Desmopressin which could result in a higher serum level. |
Doripenem Injection | Doripenem Injection Amphotericin B may decrease the excretion rate of Doripenem which could result in a higher serum level. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection Amphotericin B may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level. |
Desvenlafaxine | Desvenlafaxine Amphotericin B may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level. |
Cevimeline | Cevimeline Amphotericin B may decrease the excretion rate of Cevimeline which could result in a higher serum level. |
Nebivolol | Nebivolol The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nebivolol. |
Tretinoin | Tretinoin The risk or severity of adverse effects can be increased when Amphotericin B is combined with Tretinoin. |
Certolizumab Injection | Certolizumab Injection Amphotericin B may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level. |
Ixabepilone Injection | Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Amphotericin B. |
Irinotecan Injection | Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Amphotericin B. |
Daptomycin Injection | Daptomycin Injection Amphotericin B may decrease the excretion rate of Daptomycin which could result in a higher serum level. |
Methylnaltrexone Injection | Methylnaltrexone Injection Amphotericin B may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. |
Rufinamide | Rufinamide The metabolism of Rufinamide can be decreased when combined with Amphotericin B. |
Midazolam | Midazolam The serum concentration of Midazolam can be increased when it is combined with Amphotericin B. |
Naltrexone Injection | Naltrexone Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Naltrexone. |
Dexrazoxane Injection | Dexrazoxane Injection Amphotericin B may decrease the excretion rate of Dexrazoxane which could result in a higher serum level. |
Milnacipran | Milnacipran Amphotericin B may decrease the excretion rate of Milnacipran which could result in a higher serum level. |
Plerixafor Injection | Plerixafor Injection Amphotericin B may decrease the excretion rate of Plerixafor which could result in a higher serum level. |
Fesoterodine | Fesoterodine Amphotericin B may decrease the excretion rate of Fesoterodine which could result in a higher serum level. |
Betaxolol | Betaxolol The risk or severity of adverse effects can be increased when Amphotericin B is combined with Betaxolol. |
Iloperidone | Iloperidone The metabolism of Iloperidone can be decreased when combined with Amphotericin B. |
Prasugrel | Prasugrel Amphotericin B may decrease the excretion rate of Prasugrel which could result in a higher serum level. |
Lacosamide | Lacosamide The metabolism of Lacosamide can be decreased when combined with Amphotericin B. |
Everolimus | Everolimus The metabolism of Everolimus can be decreased when combined with Amphotericin B. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Amphotericin B. |
Dronedarone | Dronedarone The metabolism of Dronedarone can be decreased when combined with Amphotericin B. |
Pralatrexate Injection | Pralatrexate Injection Amphotericin B may decrease the excretion rate of Pralatrexate which could result in a higher serum level. |
Palonosetron Injection | Palonosetron Injection Amphotericin B may decrease the excretion rate of Palonosetron which could result in a higher serum level. |
Saxagliptin | Saxagliptin Amphotericin B may decrease the excretion rate of Saxagliptin which could result in a higher serum level. |
Telavancin Injection | Telavancin Injection Amphotericin B may decrease the excretion rate of Telavancin which could result in a higher serum level. |
Romidepsin Injection | Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Amphotericin B. |
Topotecan | Topotecan Amphotericin B may decrease the excretion rate of Topotecan which could result in a higher serum level. |
Pazopanib | Pazopanib The metabolism of Pazopanib can be decreased when combined with Amphotericin B. |
Vigabatrin | Vigabatrin The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Amphotericin B. |
Pitavastatin | Pitavastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Pitavastatin. |
Albendazole | Albendazole The metabolism of Albendazole can be decreased when combined with Amphotericin B. |
Dalfampridine | Dalfampridine The risk or severity of seizure can be increased when Amphotericin B is combined with Dalfampridine. |
Cabazitaxel Injection | Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Amphotericin B. |
Ceftaroline Injection | Ceftaroline Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Ceftaroline fosamil. |
Acetaminophen Injection | Acetaminophen Injection Amphotericin B may decrease the excretion rate of Acetaminophen which could result in a higher serum level. |
Ipilimumab Injection | Ipilimumab Injection Amphotericin B may decrease the excretion rate of Ipilimumab which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection Amphotericin B may decrease the excretion rate of Aldesleukin which could result in a higher serum level. |
Terbutaline Injection | Terbutaline Injection Amphotericin B may decrease the excretion rate of Terbutaline which could result in a higher serum level. |
Azilsartan | Azilsartan The risk or severity of adverse effects can be increased when Amphotericin B is combined with Azilsartan medoxomil. |
Busulfan Injection | Busulfan Injection The metabolism of Busulfan can be decreased when combined with Amphotericin B. |
Roflumilast | Roflumilast Amphotericin B may decrease the excretion rate of Roflumilast which could result in a higher serum level. |
Linagliptin | Linagliptin The metabolism of Linagliptin can be decreased when combined with Amphotericin B. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Amphotericin B. |
Rivaroxaban | Rivaroxaban Amphotericin B may decrease the excretion rate of Rivaroxaban which could result in a higher serum level. |
Brentuximab Vedotin Injection | Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Amphotericin B. |
Ruxolitinib | Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Amphotericin B. |
Vandetanib | Vandetanib The metabolism of Vandetanib can be decreased when combined with Amphotericin B. |
Clobazam | Clobazam Amphotericin B may decrease the excretion rate of Clobazam which could result in a higher serum level. |
Vemurafenib | Vemurafenib The metabolism of Vemurafenib can be decreased when combined with Amphotericin B. |
Deferiprone | Deferiprone Amphotericin B may decrease the excretion rate of Deferiprone which could result in a higher serum level. |
Axitinib | Axitinib The metabolism of Axitinib can be decreased when combined with Amphotericin B. |
Crizotinib | Crizotinib The metabolism of Crizotinib can be decreased when combined with Amphotericin B. |
Cabergoline | Cabergoline The metabolism of Cabergoline can be decreased when combined with Amphotericin B. |
Naloxone Injection | Naloxone Injection Amphotericin B may decrease the excretion rate of Naloxone which could result in a higher serum level. |
Ambrisentan | Ambrisentan Amphotericin B may increase the hypotensive activities of Ambrisentan. |
Fondaparinux Injection | Fondaparinux Injection Amphotericin B may decrease the excretion rate of Fondaparinux which could result in a higher serum level. |
Ezogabine | Ezogabine The therapeutic efficacy of Tiagabine can be decreased when used in combination with Amphotericin B. |
Iloprost | Iloprost The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Iloprost. |
Enzalutamide | Enzalutamide Amphotericin B may decrease the excretion rate of Enzalutamide which could result in a higher serum level. |
Mirabegron | Mirabegron Amphotericin B may decrease the excretion rate of Mirabegron which could result in a higher serum level. |
Regorafenib | Regorafenib The metabolism of Regorafenib can be decreased when combined with Amphotericin B. |
Bosutinib | Bosutinib The metabolism of Bosutinib can be decreased when combined with Amphotericin B. |
Corticotropin, Repository Injection | Corticotropin, Repository Injection The risk or severity of hypokalemia can be increased when Corticotropin is combined with Amphotericin B. |
Teduglutide Injection | Teduglutide Injection Amphotericin B may decrease the excretion rate of Teduglutide which could result in a higher serum level. |
Tofacitinib | Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Amphotericin B. |
Alogliptin | Alogliptin Amphotericin B may decrease the excretion rate of Alogliptin which could result in a higher serum level. |
Ponatinib | Ponatinib The metabolism of Ponatinib can be decreased when combined with Amphotericin B. |
Pomalidomide | Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Amphotericin B. |
Ado-trastuzumab Emtansine Injection | Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Amphotericin B. |
Canagliflozin | Canagliflozin Amphotericin B may decrease the excretion rate of Canagliflozin which could result in a higher serum level. |
Methazolamide | Methazolamide The risk or severity of adverse effects can be increased when Amphotericin B is combined with Methazolamide. |
Dabrafenib | Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Amphotericin B. |
Trametinib | Trametinib Amphotericin B may decrease the excretion rate of Trametinib which could result in a higher serum level. |
Levomilnacipran | Levomilnacipran Amphotericin B may decrease the excretion rate of Levomilnacipran which could result in a higher serum level. |
Ertapenem Injection | Ertapenem Injection Amphotericin B may decrease the excretion rate of Ertapenem which could result in a higher serum level. |
Vortioxetine | Vortioxetine Amphotericin B may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Perampanel | Perampanel The therapeutic efficacy of Perampanel can be decreased when used in combination with Amphotericin B. |
Ibrutinib | Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Amphotericin B. |
Lomitapide | Lomitapide The metabolism of Lomitapide can be decreased when combined with Amphotericin B. |
Avanafil | Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Amphotericin B. |
Ketorolac Injection | Ketorolac Injection The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Amphotericin B. |
Obinutuzumab Injection | Obinutuzumab Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Obinutuzumab. |
Sofosbuvir | Sofosbuvir Amphotericin B may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin The risk or severity of adverse effects can be increased when Amphotericin B is combined with Dapagliflozin. |
Apremilast | Apremilast Amphotericin B may decrease the excretion rate of Apremilast which could result in a higher serum level. |
Droxidopa | Droxidopa Amphotericin B may decrease the excretion rate of Droxidopa which could result in a higher serum level. |
Ceritinib | Ceritinib The metabolism of Ceritinib can be decreased when combined with Amphotericin B. |
Eslicarbazepine | Eslicarbazepine The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Amphotericin B. |
Idelalisib | Idelalisib The metabolism of Idelalisib can be decreased when combined with Amphotericin B. |
Testosterone Injection | Testosterone Injection Amphotericin B may decrease the excretion rate of Testosterone which could result in a higher serum level. |
Empagliflozin | Empagliflozin The risk or severity of adverse effects can be increased when Amphotericin B is combined with Empagliflozin. |
Vorapaxar | Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Amphotericin B. |
Suvorexant | Suvorexant The metabolism of Suvorexant can be decreased when combined with Amphotericin B. |
Edoxaban | Edoxaban Amphotericin B may decrease the excretion rate of Edoxaban which could result in a higher serum level. |
Olaparib | Olaparib The metabolism of Olaparib can be decreased when combined with Amphotericin B. |
Methamphetamine | Methamphetamine Amphotericin B may decrease the excretion rate of Metamfetamine which could result in a higher serum level. |
Tasimelteon | Tasimelteon Amphotericin B may decrease the excretion rate of Tasimelteon which could result in a higher serum level. |
Riociguat | Riociguat The risk or severity of adverse effects can be increased when Amphotericin B is combined with Riociguat. |
Nintedanib | Nintedanib The metabolism of Nintedanib can be decreased when combined with Amphotericin B. |
Risperidone Injection | Risperidone Injection Amphotericin B may increase the hypotensive activities of Risperidone. |
Palbociclib | Palbociclib The metabolism of Palbociclib can be decreased when combined with Amphotericin B. |
Panobinostat | Panobinostat The metabolism of Panobinostat can be decreased when combined with Amphotericin B. |
Dinutuximab Injection | Dinutuximab Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Dinutuximab. |
Haloperidol Injection | Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Amphotericin B. |
Amiloride | Amiloride The risk or severity of adverse effects can be increased when Amiloride is combined with Amphotericin B. |
Isavuconazonium Injection | Isavuconazonium Injection The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Isavuconazonium. |
Macitentan | Macitentan Amphotericin B may decrease the excretion rate of Macitentan which could result in a higher serum level. |
Sonidegib | Sonidegib The metabolism of Sonidegib can be decreased when combined with Amphotericin B. |
Prednisolone | Prednisolone The risk or severity of hypokalemia can be increased when Prednisolone is combined with Amphotericin B. |
Ziprasidone Injection | Ziprasidone Injection The metabolism of Ziprasidone can be decreased when combined with Amphotericin B. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Amphotericin B may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Cobimetinib | Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Amphotericin B. |
Trabectedin Injection | Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Amphotericin B. |
Osimertinib | Osimertinib The metabolism of Osimertinib can be decreased when combined with Amphotericin B. |
Alectinib | Alectinib The metabolism of Alectinib can be decreased when combined with Amphotericin B. |
Ixazomib | Ixazomib The metabolism of Ixazomib can be decreased when combined with Amphotericin B. |
Lesinurad | Lesinurad Amphotericin B may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Dexamethasone Injection | Dexamethasone Injection The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Amphotericin B. |
Brivaracetam Injection | Brivaracetam Injection Amphotericin B may decrease the excretion rate of Brivaracetam which could result in a higher serum level. |
Venetoclax | Venetoclax The metabolism of Venetoclax can be decreased when combined with Amphotericin B. |
Selexipag | Selexipag Amphotericin B may increase the hypotensive activities of Selexipag. |
Furosemide Injection | Furosemide Injection Amphotericin B may decrease the excretion rate of Furosemide which could result in a higher serum level. |
Lixisenatide Injection | Lixisenatide Injection Amphotericin B may decrease the excretion rate of Lixisenatide which could result in a higher serum level. |
Ribociclib | Ribociclib The metabolism of Ribociclib can be decreased when combined with Amphotericin B. |
Brigatinib | Brigatinib The metabolism of Brigatinib can be decreased when combined with Amphotericin B. |
Doxepin (Insomnia) | Doxepin (Insomnia) Amphotericin B may decrease the excretion rate of Doxepin which could result in a higher serum level. |
Deutetrabenazine | Deutetrabenazine Amphotericin B may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level. |
Valbenazine | Valbenazine Amphotericin B may decrease the excretion rate of Valbenazine which could result in a higher serum level. |
Deflazacort | Deflazacort The risk or severity of hypokalemia can be increased when Deflazacort is combined with Amphotericin B. |
Safinamide | Safinamide Safinamide may increase the orthostatic hypotensive activities of Amphotericin B. |
Naldemedine | Naldemedine Amphotericin B may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Midostaurin | Midostaurin The metabolism of Midostaurin can be decreased when combined with Amphotericin B. |
Neratinib | Neratinib The metabolism of Neratinib can be decreased when combined with Amphotericin B. |
Enasidenib | Enasidenib The metabolism of Enasidenib can be decreased when combined with Amphotericin B. |
Aprepitant/Fosaprepitant Injection | Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Amphotericin B. |
Benznidazole | Benznidazole Amphotericin B may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Copanlisib Injection | Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Amphotericin B. |
Delafloxacin | Delafloxacin Amphotericin B may decrease the excretion rate of Delafloxacin which could result in a higher serum level. |
Abemaciclib | Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Amphotericin B. |
Acalabrutinib | Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Amphotericin B. |
Apalutamide | Apalutamide Amphotericin B may decrease the excretion rate of Apalutamide which could result in a higher serum level. |
Penicillamine | Penicillamine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Penicillamine. |
Fostamatinib | Fostamatinib The risk or severity of hypotension can be increased when Fostamatinib is combined with Amphotericin B. |
Baricitinib | Baricitinib The metabolism of Baricitinib can be decreased when combined with Amphotericin B. |
Lofexidine | Lofexidine Amphotericin B may decrease the excretion rate of Lofexidine which could result in a higher serum level. |
Plazomicin Injection | Plazomicin Injection Amphotericin B may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Eliglustat | Eliglustat The metabolism of Eliglustat can be decreased when combined with Amphotericin B. |
Ivosidenib | Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Amphotericin B. |
Cannabidiol | Cannabidiol The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Amphotericin B. |
Dacomitinib | Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Amphotericin B. |
Duvelisib | Duvelisib The metabolism of Duvelisib can be decreased when combined with Amphotericin B. |
Stiripentol | Stiripentol Amphotericin B may decrease the excretion rate of Stiripentol which could result in a higher serum level. |
Gilteritinib | Gilteritinib The metabolism of Gilteritinib can be decreased when combined with Amphotericin B. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Amphotericin B. |
Prucalopride | Prucalopride The metabolism of Prucalopride can be decreased when combined with Amphotericin B. |
Siponimod | Siponimod The metabolism of Siponimod can be decreased when combined with Amphotericin B. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Amphotericin B may decrease the excretion rate of Acyclovir which could result in a higher serum level. |
Erdafitinib | Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Amphotericin B. |
Alpelisib | Alpelisib The metabolism of Alpelisib can be decreased when combined with Amphotericin B. |
Brexanolone Injection | Brexanolone Injection The therapeutic efficacy of Brexanolone can be decreased when used in combination with Amphotericin B. |
Cladribine | Cladribine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Amphotericin B. |
Solriamfetol | Solriamfetol Amphotericin B may decrease the excretion rate of Solriamfetol which could result in a higher serum level. |
Entrectinib | Entrectinib The metabolism of Entrectinib can be decreased when combined with Amphotericin B. |
Pexidartinib | Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Amphotericin B. |
Pitolisant | Pitolisant Amphotericin B may decrease the excretion rate of Pitolisant which could result in a higher serum level. |
Lefamulin | Lefamulin The metabolism of Lefamulin can be decreased when combined with Amphotericin B. |
Phenytoin Injection | Phenytoin Injection The therapeutic efficacy of Phenytoin can be decreased when used in combination with Amphotericin B. |
Fosphenytoin Injection | Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Amphotericin B. |
Zanubrutinib | Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Amphotericin B. |
Voxelotor | Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Amphotericin B. |
Tazemetostat | Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Amphotericin B. |
Cenobamate | Cenobamate The therapeutic efficacy of Cenobamate can be decreased when used in combination with Amphotericin B. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Amphotericin B. |
Viloxazine | Viloxazine Amphotericin B may decrease the excretion rate of Viloxazine which could result in a higher serum level. |
Tobramycin Injection | Tobramycin Injection Amphotericin B may decrease the excretion rate of Tobramycin which could result in a higher serum level. |
Theophylline | Theophylline The metabolism of Theophylline can be decreased when combined with Amphotericin B. |
Fenoprofen | Fenoprofen The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Amphotericin B. |
Indomethacin | Indomethacin The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Amphotericin B. |
Mefenamic Acid | Mefenamic Acid The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Mefenamic acid. |
Naproxen | Naproxen The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Naproxen. |
Tolmetin | Tolmetin The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Amphotericin B. |
Sulindac | Sulindac The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Amphotericin B. |
Isotretinoin | Isotretinoin Amphotericin B may decrease the excretion rate of Isotretinoin which could result in a higher serum level. |
Sucralfate | Sucralfate Amphotericin B may decrease the excretion rate of Sucralfate which could result in a higher serum level. |
Floxuridine | Floxuridine Amphotericin B may decrease the excretion rate of Floxuridine which could result in a higher serum level. |
Phenobarbital | Phenobarbital Phenobarbital may increase the hypotensive activities of Amphotericin B. |
Metaxalone | Metaxalone Amphotericin B may decrease the excretion rate of Metaxalone which could result in a higher serum level. |
Methotrexate Injection | Methotrexate Injection The metabolism of Methotrexate can be decreased when combined with Amphotericin B. |
Primidone | Primidone Primidone may increase the hypotensive activities of Amphotericin B. |
Methsuximide | Methsuximide Methsuximide may decrease the nephrotoxic activities of Amphotericin B. |
Chlorpromazine | Chlorpromazine Amphotericin B may decrease the excretion rate of Chlorpromazine which could result in a higher serum level. |
Diazepam | Diazepam Amphotericin B may decrease the excretion rate of Diazepam which could result in a higher serum level. |
Oxazepam | Oxazepam Amphotericin B may decrease the excretion rate of Oxazepam which could result in a higher serum level. |
Flurazepam | Flurazepam Amphotericin B may decrease the excretion rate of Flurazepam which could result in a higher serum level. |
Clorazepate | Clorazepate Amphotericin B may decrease the excretion rate of Clorazepic acid which could result in a higher serum level. |
Lorazepam | Lorazepam Amphotericin B may decrease the excretion rate of Lorazepam which could result in a higher serum level. |
Phenoxybenzamine | Phenoxybenzamine The risk or severity of adverse effects can be increased when Amphotericin B is combined with Phenoxybenzamine. |
Carmustine | Carmustine Amphotericin B may decrease the excretion rate of Carmustine which could result in a higher serum level. |
Amantadine | Amantadine Amphotericin B may decrease the excretion rate of Amantadine which could result in a higher serum level. |
Codeine | Codeine Amphotericin B may decrease the excretion rate of Codeine which could result in a higher serum level. |
Bromocriptine | Bromocriptine The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bromocriptine. |
Tranylcypromine | Tranylcypromine Tranylcypromine may increase the orthostatic hypotensive activities of Amphotericin B. |
Phenelzine | Phenelzine Phenelzine may increase the orthostatic hypotensive activities of Amphotericin B. |
Procarbazine | Procarbazine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Procarbazine. |
Tetracycline | Tetracycline Amphotericin B may decrease the excretion rate of Tetracycline which could result in a higher serum level. |
Minocycline | Minocycline The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Minocycline. |
Prochlorperazine | Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Amphotericin B. |
Thioridazine | Thioridazine The risk or severity of adverse effects can be increased when Thioridazine is combined with Amphotericin B. |
Bleomycin | Bleomycin Amphotericin B may decrease the excretion rate of Bleomycin which could result in a higher serum level. |
Sulfadiazine | Sulfadiazine Amphotericin B may decrease the excretion rate of Sulfadiazine which could result in a higher serum level. |
Methadone | Methadone Amphotericin B may decrease the excretion rate of Methadone which could result in a higher serum level. |
Benztropine | Benztropine Amphotericin B may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Maprotiline | Maprotiline Amphotericin B may decrease the excretion rate of Maprotiline which could result in a higher serum level. |
Ibuprofen | Ibuprofen Amphotericin B may decrease the excretion rate of Ibuprofen which could result in a higher serum level. |
Azathioprine | Azathioprine Amphotericin B may decrease the excretion rate of Azathioprine which could result in a higher serum level. |
Phentermine | Phentermine The metabolism of Phentermine can be decreased when combined with Amphotericin B. |
Methylphenidate | Methylphenidate Amphotericin B may decrease the excretion rate of Methylphenidate which could result in a higher serum level. |
Sulfasalazine | Sulfasalazine The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Sulfasalazine. |
Hydrocortisone | Hydrocortisone The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Amphotericin B. |
Doxorubicin | Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Amphotericin B. |
Cytarabine | Cytarabine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Cytarabine. |
Phenazopyridine | Phenazopyridine The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Phenazopyridine. |
Carbamazepine | Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Amphotericin B. |
Methyldopa | Methyldopa Amphotericin B may decrease the excretion rate of Methyldopa which could result in a higher serum level. |
Clonidine | Clonidine The metabolism of Clonidine can be decreased when combined with Amphotericin B. |
Prazosin | Prazosin The risk or severity of adverse effects can be increased when Amphotericin B is combined with Prazosin. |
Hydralazine | Hydralazine Amphotericin B may decrease the excretion rate of Hydralazine which could result in a higher serum level. |
Cimetidine | Cimetidine Amphotericin B may decrease the excretion rate of Cimetidine which could result in a higher serum level. |
Gentamicin Injection | Gentamicin Injection Amphotericin B may decrease the excretion rate of Gentamicin which could result in a higher serum level. |
Warfarin | Warfarin The serum concentration of Warfarin can be increased when it is combined with Amphotericin B. |
Clonazepam | Clonazepam Amphotericin B may decrease the excretion rate of Clonazepam which could result in a higher serum level. |
Loperamide | Loperamide Loperamide may decrease the nephrotoxic activities of Amphotericin B. |
Promethazine | Promethazine Amphotericin B may decrease the excretion rate of Promethazine which could result in a higher serum level. |
Meclofenamate | Meclofenamate Amphotericin B may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level. |
Nitrofurantoin | Nitrofurantoin Amphotericin B may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level. |
Digoxin | Digoxin The risk or severity of adverse effects can be increased when Amphotericin B is combined with Digoxin. |
Chloroquine | Chloroquine Amphotericin B may decrease the excretion rate of Chloroquine which could result in a higher serum level. |
Ethosuximide | Ethosuximide Ethosuximide may decrease the nephrotoxic activities of Amphotericin B. |
Triamterene | Triamterene The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Amphotericin B. |
Lactulose | Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Amphotericin B. |
Chlorothiazide | Chlorothiazide The risk or severity of electrolyte imbalance can be increased when Amphotericin B is combined with Chlorothiazide. |
Chlorthalidone | Chlorthalidone The risk or severity of adverse effects can be increased when Amphotericin B is combined with Chlorthalidone. |
Metolazone | Metolazone Amphotericin B may decrease the excretion rate of Metolazone which could result in a higher serum level. |
Secobarbital | Secobarbital Secobarbital may increase the hypotensive activities of Amphotericin B. |
Desipramine | Desipramine Amphotericin B may decrease the excretion rate of Desipramine which could result in a higher serum level. |
Amitriptyline | Amitriptyline Amphotericin B may decrease the excretion rate of Amitriptyline which could result in a higher serum level. |
Imipramine | Imipramine Amphotericin B may decrease the excretion rate of Imipramine which could result in a higher serum level. |
Probenecid | Probenecid Amphotericin B may decrease the excretion rate of Probenecid which could result in a higher serum level. |
Quinidine | Quinidine The metabolism of Quinidine can be decreased when combined with Amphotericin B. |
Procainamide | Procainamide Amphotericin B may decrease the excretion rate of Procainamide which could result in a higher serum level. |
Isoniazid | Isoniazid Amphotericin B may decrease the excretion rate of Isoniazid which could result in a higher serum level. |
Pyrazinamide | Pyrazinamide Amphotericin B may decrease the excretion rate of Pyrazinamide which could result in a higher serum level. |
Disopyramide | Disopyramide Amphotericin B may decrease the excretion rate of Disopyramide which could result in a higher serum level. |
Valproic Acid | Valproic Acid The therapeutic efficacy of Valproic acid can be decreased when used in combination with Amphotericin B. |
Tamoxifen | Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Amphotericin B. |
Butabarbital | Butabarbital Amphotericin B may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Liothyronine | Liothyronine Amphotericin B may decrease the excretion rate of Liothyronine which could result in a higher serum level. |
Methimazole | Methimazole Amphotericin B may decrease the excretion rate of Methimazole which could result in a higher serum level. |
Propylthiouracil | Propylthiouracil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Amphotericin B. |
Chlorpropamide | Chlorpropamide Amphotericin B may decrease the excretion rate of Chlorpropamide which could result in a higher serum level. |
Tolbutamide | Tolbutamide Amphotericin B may decrease the excretion rate of Tolbutamide which could result in a higher serum level. |
Tolazamide | Tolazamide Amphotericin B may decrease the excretion rate of Tolazamide which could result in a higher serum level. |
Niacin | Niacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Amphotericin B. |
Baclofen | Baclofen Amphotericin B may decrease the excretion rate of Baclofen which could result in a higher serum level. |
Ethambutol | Ethambutol Amphotericin B may decrease the excretion rate of Ethambutol which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide The risk or severity of electrolyte imbalance can be increased when Methyclothiazide is combined with Amphotericin B. |
Hydrochlorothiazide | Hydrochlorothiazide The risk or severity of electrolyte imbalance can be increased when Amphotericin B is combined with Hydrochlorothiazide. |
Chlorzoxazone | Chlorzoxazone Amphotericin B may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level. |
Pyridoxine | Pyridoxine Amphotericin B may decrease the excretion rate of Pyridoxine which could result in a higher serum level. |
Folic Acid | Folic Acid Amphotericin B may decrease the excretion rate of Folic acid which could result in a higher serum level. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) Amphotericin B may decrease the excretion rate of Propranolol which could result in a higher serum level. |
Minoxidil | Minoxidil The risk or severity of adverse effects can be increased when Amphotericin B is combined with Minoxidil. |
Nortriptyline | Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Amphotericin B. |
Spironolactone | Spironolactone The risk or severity of adverse effects can be increased when Spironolactone is combined with Amphotericin B. |
Phytonadione | Phytonadione Amphotericin B may decrease the excretion rate of Phylloquinone which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Amikacin may decrease the excretion rate of Amphotericin B which could result in a higher serum level. |
Nadolol | Nadolol Amphotericin B may decrease the excretion rate of Nadolol which could result in a higher serum level. |
Allopurinol | Allopurinol Amphotericin B may decrease the excretion rate of Allopurinol which could result in a higher serum level. |
Flavoxate | Flavoxate Amphotericin B may decrease the excretion rate of Flavoxate which could result in a higher serum level. |
Papaverine | Papaverine The risk or severity of adverse effects can be increased when Amphotericin B is combined with Papaverine. |
Colchicine | Colchicine The metabolism of Colchicine can be decreased when combined with Amphotericin B. |
Cefaclor | Cefaclor Amphotericin B may decrease the excretion rate of Cefaclor which could result in a higher serum level. |
Cefadroxil | Cefadroxil Amphotericin B may decrease the excretion rate of Cefadroxil which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefazolin. |
Cephalexin | Cephalexin Amphotericin B may decrease the excretion rate of Cephalexin which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefoxitin. |
Dacarbazine | Dacarbazine Amphotericin B may decrease the excretion rate of Dacarbazine which could result in a higher serum level. |
Acetazolamide | Acetazolamide The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Amphotericin B. |
Cefotaxime Injection | Cefotaxime Injection The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Amphotericin B. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Amphotericin B may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level. |
Ketoconazole | Ketoconazole The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Ketoconazole. |
Pyrantel | Pyrantel Amphotericin B may decrease the excretion rate of Pyrantel which could result in a higher serum level. |
Thiotepa Injection | Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Amphotericin B. |
Vincristine Injection | Vincristine Injection The metabolism of Amphotericin B can be decreased when combined with Vincristine. |
Captopril | Captopril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Captopril. |
Dipyridamole | Dipyridamole The risk or severity of adverse effects can be increased when Amphotericin B is combined with Dipyridamole. |
Isoxsuprine | Isoxsuprine The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isoxsuprine. |
Vinblastine | Vinblastine The metabolism of Vinblastine can be decreased when combined with Amphotericin B. |
Ethacrynic Acid | Ethacrynic Acid The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Etacrynic acid. |
Colistimethate Injection | Colistimethate Injection Amphotericin B may increase the nephrotoxic activities of Colistimethate. |
Metoprolol | Metoprolol Amphotericin B may decrease the excretion rate of Metoprolol which could result in a higher serum level. |
Aspirin | Aspirin The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Acetylsalicylic acid. |
Salsalate | Salsalate The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Salsalate. |
Alprazolam | Alprazolam The metabolism of Alprazolam can be decreased when combined with Amphotericin B. |
Temazepam | Temazepam Amphotericin B may decrease the excretion rate of Temazepam which could result in a higher serum level. |
Triazolam | Triazolam Amphotericin B may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Dicyclomine | Dicyclomine Amphotericin B may decrease the excretion rate of Dicyclomine which could result in a higher serum level. |
Propantheline | Propantheline Amphotericin B may decrease the excretion rate of Propantheline which could result in a higher serum level. |
Trimethoprim | Trimethoprim Amphotericin B may decrease the excretion rate of Trimethoprim which could result in a higher serum level. |
Diltiazem | Diltiazem Diltiazem may decrease the nephrotoxic activities of Amphotericin B. |
Nifedipine | Nifedipine Nifedipine may decrease the nephrotoxic activities of Amphotericin B. |
Timolol | Timolol Amphotericin B may decrease the excretion rate of Timolol which could result in a higher serum level. |
Verapamil | Verapamil Verapamil may decrease the nephrotoxic activities of Amphotericin B. |
Atenolol | Atenolol The risk or severity of adverse effects can be increased when Amphotericin B is combined with Atenolol. |
Pindolol | Pindolol Amphotericin B may decrease the excretion rate of Pindolol which could result in a higher serum level. |
Cisplatin Injection | Cisplatin Injection Amphotericin B may decrease the excretion rate of Cisplatin which could result in a higher serum level. |
Diflunisal | Diflunisal Amphotericin B may decrease the excretion rate of Diflunisal which could result in a higher serum level. |
Piroxicam | Piroxicam Amphotericin B may decrease the excretion rate of Piroxicam which could result in a higher serum level. |
Bumetanide | Bumetanide Amphotericin B may decrease the excretion rate of Bumetanide which could result in a higher serum level. |
Etoposide | Etoposide The metabolism of Etoposide can be decreased when combined with Amphotericin B. |
Glipizide | Glipizide Amphotericin B may decrease the excretion rate of Glipizide which could result in a higher serum level. |
Indapamide | Indapamide Amphotericin B may decrease the excretion rate of Indapamide which could result in a higher serum level. |
Amoxicillin | Amoxicillin Amphotericin B may decrease the excretion rate of Amoxicillin which could result in a higher serum level. |
Oxacillin Injection | Oxacillin Injection Amphotericin B may decrease the excretion rate of Oxacillin which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline Amphotericin B may decrease the excretion rate of Pentoxifylline which could result in a higher serum level. |
Pentamidine Injection | Pentamidine Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Pentamidine. |
Ceftriaxone Injection | Ceftriaxone Injection Amphotericin B may decrease the excretion rate of Ceftriaxone which could result in a higher serum level. |
Labetalol | Labetalol Amphotericin B may decrease the excretion rate of Labetalol which could result in a higher serum level. |
Auranofin | Auranofin Amphotericin B may decrease the excretion rate of Auranofin which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection Amphotericin B may decrease the excretion rate of Leuprolide which could result in a higher serum level. |
Gemfibrozil | Gemfibrozil Amphotericin B may decrease the excretion rate of Gemfibrozil which could result in a higher serum level. |
Guanabenz | Guanabenz Amphotericin B may increase the hypotensive activities of Guanabenz. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Adefovir dipivoxil. |
Ceftazidime Injection | Ceftazidime Injection Amphotericin B may decrease the excretion rate of Ceftazidime which could result in a higher serum level. |
Ketoprofen | Ketoprofen Amphotericin B may decrease the excretion rate of Ketoprofen which could result in a higher serum level. |
Cefotetan Injection | Cefotetan Injection Amphotericin B may decrease the excretion rate of Cefotetan which could result in a higher serum level. |
Pimozide | Pimozide The metabolism of Pimozide can be decreased when combined with Amphotericin B. |
Enalapril | Enalapril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Amphotericin B. |
Flurbiprofen | Flurbiprofen Amphotericin B may decrease the excretion rate of Flurbiprofen which could result in a higher serum level. |
Amiodarone | Amiodarone Amiodarone may decrease the nephrotoxic activities of Amphotericin B. |
Aztreonam Injection | Aztreonam Injection Amphotericin B may decrease the excretion rate of Aztreonam which could result in a higher serum level. |
Buspirone | Buspirone Amphotericin B may decrease the excretion rate of Buspirone which could result in a higher serum level. |
Lovastatin | Lovastatin The metabolism of Lovastatin can be decreased when combined with Amphotericin B. |
Ciprofloxacin | Ciprofloxacin Amphotericin B may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. |
Mesalamine | Mesalamine The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Amphotericin B. |
Diclofenac | Diclofenac The risk or severity of nephrotoxicity can be increased when Diclofenac is combined with Amphotericin B. |
Nimodipine | Nimodipine Nimodipine may decrease the nephrotoxic activities of Amphotericin B. |
Clozapine | Clozapine Clozapine may decrease the excretion rate of Amphotericin B which could result in a higher serum level. |
Estazolam | Estazolam Amphotericin B may decrease the excretion rate of Estazolam which could result in a higher serum level. |
Ofloxacin | Ofloxacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Ofloxacin. |
Didanosine | Didanosine Amphotericin B may decrease the excretion rate of Didanosine which could result in a higher serum level. |
Pentostatin Injection | Pentostatin Injection Amphotericin B may decrease the excretion rate of Pentostatin which could result in a higher serum level. |
Benazepril | Benazepril The risk or severity of adverse effects can be increased when Amphotericin B is combined with Benazepril. |
Etodolac | Etodolac Amphotericin B may decrease the excretion rate of Etodolac which could result in a higher serum level. |
Felodipine | Felodipine Felodipine may decrease the nephrotoxic activities of Amphotericin B. |
Fosinopril | Fosinopril Amphotericin B may decrease the excretion rate of Fosinopril which could result in a higher serum level. |
Nabumetone | Nabumetone The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Amphotericin B. |
Pravastatin | Pravastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Amphotericin B. |
Quinapril | Quinapril The risk or severity of adverse effects can be increased when Amphotericin B is combined with Quinapril. |
Ramipril | Ramipril The risk or severity of adverse effects can be increased when Amphotericin B is combined with Ramipril. |
Simvastatin | Simvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Simvastatin is combined with Amphotericin B. |
Amlodipine | Amlodipine Amlodipine may decrease the nephrotoxic activities of Amphotericin B. |
Teniposide Injection | Teniposide Injection The metabolism of Teniposide can be decreased when combined with Amphotericin B. |
Itraconazole | Itraconazole The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Itraconazole. |
Lisinopril | Lisinopril Amphotericin B may decrease the excretion rate of Lisinopril which could result in a higher serum level. |
Oxaprozin | Oxaprozin Amphotericin B may decrease the excretion rate of Oxaprozin which could result in a higher serum level. |
Sotalol | Sotalol The risk or severity of adverse effects can be increased when Sotalol is combined with Amphotericin B. |
Bisoprolol | Bisoprolol Amphotericin B may decrease the excretion rate of Bisoprolol which could result in a higher serum level. |
Doxazosin | Doxazosin The metabolism of Doxazosin can be decreased when combined with Amphotericin B. |
Terazosin | Terazosin The risk or severity of adverse effects can be increased when Amphotericin B is combined with Terazosin. |
Isradipine | Isradipine Isradipine may decrease the nephrotoxic activities of Amphotericin B. |
Cisapride | Cisapride The metabolism of Cisapride can be decreased when combined with Amphotericin B. |
Gabapentin | Gabapentin The therapeutic efficacy of Gabapentin can be decreased when used in combination with Amphotericin B. |
Fluvastatin | Fluvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Fluvastatin. |
Venlafaxine | Venlafaxine Amphotericin B may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Nizatidine | Nizatidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Amphotericin B. |
Stavudine | Stavudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Amphotericin B. |
Famciclovir | Famciclovir The metabolism of Famciclovir can be decreased when combined with Amphotericin B. |
Fluvoxamine | Fluvoxamine Amphotericin B may decrease the excretion rate of Fluvoxamine which could result in a higher serum level. |
Nefazodone | Nefazodone Amphotericin B may decrease the excretion rate of Nefazodone which could result in a higher serum level. |
Lamotrigine | Lamotrigine Lamotrigine may decrease the nephrotoxic activities of Amphotericin B. |
Losartan | Losartan The risk or severity of adverse effects can be increased when Amphotericin B is combined with Losartan. |
Valacyclovir | Valacyclovir Amphotericin B may decrease the excretion rate of Valaciclovir which could result in a higher serum level. |
Tramadol | Tramadol The metabolism of Tramadol can be decreased when combined with Amphotericin B. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Amphotericin B. |
Carboplatin Injection | Carboplatin Injection Amphotericin B may decrease the excretion rate of Carboplatin which could result in a higher serum level. |
Moexipril | Moexipril The risk or severity of adverse effects can be increased when Amphotericin B is combined with Moexipril. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Amphotericin B. |
Nicardipine | Nicardipine Nicardipine may decrease the nephrotoxic activities of Amphotericin B. |
Bupropion | Bupropion The risk or severity of seizure can be increased when Amphotericin B is combined with Bupropion. |
Ticlopidine | Ticlopidine Amphotericin B may decrease the excretion rate of Ticlopidine which could result in a higher serum level. |
Saquinavir | Saquinavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Saquinavir. |
Metformin | Metformin Amphotericin B may decrease the excretion rate of Metformin which could result in a higher serum level. |
Nisoldipine | Nisoldipine Nisoldipine may decrease the nephrotoxic activities of Amphotericin B. |
Lamivudine | Lamivudine Amphotericin B may decrease the excretion rate of Lamivudine which could result in a higher serum level. |
Riluzole | Riluzole The therapeutic efficacy of Riluzole can be decreased when used in combination with Amphotericin B. |
Amifostine Injection | Amifostine Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Amifostine. |
Acarbose | Acarbose Amphotericin B may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Gemcitabine Injection | Gemcitabine Injection Amphotericin B may decrease the excretion rate of Gemcitabine which could result in a higher serum level. |
Indinavir | Indinavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Amphotericin B. |
Ritonavir | Ritonavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ritonavir is combined with Amphotericin B. |
Docetaxel Injection | Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Amphotericin B. |
Cidofovir Injection | Cidofovir Injection Amphotericin B may decrease the excretion rate of Cidofovir which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Amphotericin B may decrease the excretion rate of Meropenem which could result in a higher serum level. |
Clomipramine | Clomipramine The metabolism of Clomipramine can be decreased when combined with Amphotericin B. |
Zafirlukast | Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Amphotericin B. |
Fosfomycin | Fosfomycin Amphotericin B may decrease the excretion rate of Fosfomycin which could result in a higher serum level. |
Trandolapril | Trandolapril The risk or severity of adverse effects can be increased when Amphotericin B is combined with Trandolapril. |
Topiramate | Topiramate Amphotericin B may decrease the excretion rate of Topiramate which could result in a higher serum level. |
Valsartan | Valsartan The risk or severity of adverse effects can be increased when Amphotericin B is combined with Valsartan. |
Pramipexole | Pramipexole Amphotericin B may decrease the excretion rate of Pramipexole which could result in a higher serum level. |
Azithromycin | Azithromycin The metabolism of Azithromycin can be decreased when combined with Amphotericin B. |
Carvedilol | Carvedilol Carvedilol may decrease the nephrotoxic activities of Amphotericin B. |
Nilutamide | Nilutamide Amphotericin B may decrease the excretion rate of Nilutamide which could result in a higher serum level. |
Flutamide | Flutamide Amphotericin B may decrease the excretion rate of Flutamide which could result in a higher serum level. |
Selegiline | Selegiline Selegiline may increase the orthostatic hypotensive activities of Amphotericin B. |
Bicalutamide | Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Amphotericin B. |
Letrozole | Letrozole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Letrozole. |
Irbesartan | Irbesartan The risk or severity of adverse effects can be increased when Amphotericin B is combined with Irbesartan. |
Tamsulosin | Tamsulosin Amphotericin B may decrease the excretion rate of Tamsulosin which could result in a higher serum level. |
Ropinirole | Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Amphotericin B. |
Quetiapine | Quetiapine Amphotericin B may decrease the excretion rate of Quetiapine which could result in a higher serum level. |
Cefepime Injection | Cefepime Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefepime. |
Cefprozil | Cefprozil The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefprozil. |
Cefpodoxime | Cefpodoxime The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefpodoxime. |
Cetirizine | Cetirizine Amphotericin B may decrease the excretion rate of Cetirizine which could result in a higher serum level. |
Tolcapone | Tolcapone Amphotericin B may decrease the excretion rate of Tolcapone which could result in a higher serum level. |
Capecitabine | Capecitabine Amphotericin B may decrease the excretion rate of Capecitabine which could result in a higher serum level. |
Abacavir | Abacavir Amphotericin B may decrease the excretion rate of Abacavir which could result in a higher serum level. |
Sildenafil | Sildenafil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Amphotericin B. |
Celecoxib | Celecoxib The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Amphotericin B. |
Rosiglitazone | Rosiglitazone Amphotericin B may decrease the excretion rate of Rosiglitazone which could result in a higher serum level. |
Tolterodine | Tolterodine Amphotericin B may decrease the excretion rate of Tolterodine which could result in a higher serum level. |
Thalidomide | Thalidomide The risk or severity of adverse effects can be increased when Amphotericin B is combined with Thalidomide. |
Oseltamivir | Oseltamivir Amphotericin B may decrease the excretion rate of Oseltamivir which could result in a higher serum level. |
Balsalazide | Balsalazide The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Balsalazide. |
Nateglinide | Nateglinide Amphotericin B may decrease the excretion rate of Nateglinide which could result in a higher serum level. |
Levetiracetam | Levetiracetam The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Amphotericin B. |
Rabeprazole | Rabeprazole Amphotericin B may decrease the excretion rate of Rabeprazole which could result in a higher serum level. |
Terbinafine | Terbinafine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Terbinafine. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists